The Pharma Industry witnessed another eventful week, with developments across regulation, innovation, manufacturing, and public health.
NITI Aayog steps up to taking the indian traditional healthcare into global attention, with further evidence-based research and development, Ayurveda is expected to be popularised globally for its efficiency in preventive healthcare solutions.
Kerala Patients have received a major reassurance after the state government ruled out the hospital privatization of any government hospitals.
The Hyderabad Pharma Firm, Shantha Biologics, has secured a major manufacturing agreement with Novo Nordisk, marking another milestone for India's pharmaceutical sector.
1.jpg "New DPCO Amendments Simplify Drug Launches, Cut Compliance Burden")
The government sets new regulatory rules on drug launches, that relieves the hurdles for Indian manufacturers in obtaining regulatory approvals for supply delays. This in turn, aims to improve the quick market entry of drugs and improve sales
India has introduced a major regulatory change for Stem Cell and Gene Therapy, bringing these advanced treatments under a central licensing framework.
EMA has recently approved Lupin's drug capsules that could change the care for the rare muscle disorder, non-dystrophic myotonias that is seen in one among a million people
Delhi's dengue fight received a major boost after Union Health Minister Jagat Prakash Nadda chaired a high-level meeting to review the city's preparedness against dengue ahead of the peak transmission season.
A new mRNA Vaccine Analysis has delivered reassuring findings about the safety and effectiveness of mRNA vaccines.
India may need to rethink its India drug rules before making changes that could impact the country's position as a global leader in affordable medicines.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")